2019. Aprepitant, a novel neurokinin-1 receptor antagonist in management of chemotherapy induces nausea vomiting (CINV) in cancer patients. International Journal of Research in Clinical and Hospital Pharmacy. 2, 1 (Sep. 2019), 1–4.